Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    23-September-2000      
Issue 163 Next Update - 14:00 UTC 08:00 EST    24-September-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya Today In Vidyyasm

Newsletter Summary For 23-September-2000:

Nearly 12,000 drug treatment programs around the country will benefit from years of drug abuse and addiction research thanks to the NIDA Clinical Toolbox: Science-Based Materials for Drug Abuse Counselors. The toolbox, packaged in a bright gray box with a large "TX" on the front, will be available later this month from the National Institute on Drug Abuse (NIDA). The online version is available now.

Medical researchers meeting in Toronto this week called for a vaccination program to combat the increasing incidence of pertussis (whooping cough) among adolescents and adults. While there is zero mortality from pertussis in adolescents and adults, those who have or are in contact with young children should be immunized in an attempt to protect infants, who do suffer morbidity and mortality. The discussion took place at the American Society for Microbiology's 40th annual conference on antimicrobial agents and chemotherapy. This issue of Vidyya has additional background information, for health professionals, about pertusis from the CDC.

Medicine is controversy. The Canadian National Breast Screening Study-2 (CNBSS-2) published Thursday in the Journal of the National Cancer Institute may be flawed because it is based on poor quality mammograms that were done before the introduction of specific training and quality accreditation in mammography and because of the basic design of the study. According to the Canadian Association of Radiologists, the CNBSS-2 falsely concludes that adding mammography for breast cancer screening to physical examinations does not reduce deaths.

In another controversial issue, the Food and Drug Administration (FDA) is set to decide the fate of mifepristone -- formerly known as RU-486, the French abortion pill -- by 30 September 2000. This political "hot potato" is an issue we're sure to hear more about over the coming week.

The articles in today's Vidyya are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.